loader image
Saturday, November 29, 2025
76.9 F
McAllen
- Advertisement -

Driscoll one of 40 hospitals nationwide participating in Pfizer trial for COVID-19 vaccine for children younger than 12

Translate to Spanish or other 102 languages!

Iris Gutierrez (from left), Sophia Gutierrez, 10, Pediatrician Valeria Munguia Jovel, MD, Erin Richmond, MS, RN, CCRP, Program Manager, Global Institute for Hispanic Health, and Jaime Fergie, MD, Director of Infectious Diseases at Driscoll Children’s Hospital and Medical Director of Driscoll’s and Texas A&M University’s Global Institute for Hispanic Health.

Mega Doctor News

- Advertisement -

CORPUS CHRISTI – Driscoll Children’s Hospital is one of 40 hospitals nationwide and 100 hospitals worldwide participating in a Pfizer clinical trial for a COVID-19 vaccine for children younger than 12. Driscoll is the only clinical trial site for South Texas.

The first participant, Sophia Gutierrez, 10, of Odem, was at Driscoll on Monday undergoing the necessary labwork and receiving her first shot.

“I really wanted to get vaccinated so I could see my grandmother and other family members,” said Sophia.

- Advertisement -

The clinical trial is open for children six months to 11 years. Driscoll Children’s Hospital and Texas A&M University’s Global Institute for Hispanic Heath are conducting the trial, but participants do not have to be Hispanic or Driscoll patients.

“The Global Institute for Hispanic Health strives to bring important clinical studies to our region. We are happy to be able to offer this COVID-19 trial to the children of South Texas,” said Jaime Fergie, MD, Director of Infectious Diseases at Driscoll Children’s Hospital and Medical Director of Driscoll’s and Texas A&M University’s Global Institute for Hispanic Health.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Behavioral Hosting Webinar on Seasonal Depression, Dec. 4

Mega Doctor News It’s common for individuals to experience an emotional downturn during the winter...

AMA Adopts New Public Health Policies to Improve Health of the Nation

The American Medical Association (AMA) gathered physician and medical student leaders from all corners of medicine at its Interim Meeting of the House of Delegates to shape guiding policies on emerging health care topics.

Study Finds Best Strategy for Reducing Belly Fat

Over the last few years, research has shown that having excessive visceral fat — the fat surrounding the abdominal area that protects internal organs — can be detrimental to a person’s health.

FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy

The U.S. Food and Drug Administration approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in the survival motor neuron 1 (SMN1) gene. Itvisma is an adeno-associated virus (AAV) vector-based gene therapy.
- Advertisement -
×